Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.

Where this comes from

• Record sourced from PubMed, PMID 38722867.
• Also identified by DOI 10.1371/journal.pone.0303776 and PMC identifier 11081227.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.